Clarus Wins Ax Of Rival's Testosterone Patent Claims
Clarus Therapeutics Inc. has convinced a federal judge to invalidate claims in four Lipocine Inc. patents that Clarus was accused of infringing with its testosterone replacement treatment Jatenzo, according to an...To view the full article, register now.
Already a subscriber? Click here to view full article